Chemomab Therapeutics Ltd. Quarterly Entity Common Stock, Shares Outstanding from Q4 2018 to Q4 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Chemomab Therapeutics Ltd. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2018 to Q4 2023.
  • Chemomab Therapeutics Ltd. Entity Common Stock, Shares Outstanding for the quarter ending December 31, 2023 was 284M shares, a 28.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 284M +63.1M +28.6% Dec 31, 2023 20-F 2024-03-28
Q1 2023 11M -217M -95.2% May 8, 2023 10-Q 2023-05-11
Q4 2022 221M Dec 31, 2022 10-K 2023-03-20
Q3 2022 11.5M +125K +1.1% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 11.4M +33.9K +0.3% Aug 11, 2022 10-Q 2022-08-12
Q1 2022 228M +191M +515% Mar 24, 2022 10-K 2022-03-30
Q3 2021 11.4M Nov 12, 2021 10-Q 2021-11-12
Q2 2021 11.4M -25.7M -69.3% Aug 13, 2021 10-Q 2021-08-13
Q1 2021 37.1M 0 0% Feb 18, 2021 10-K 2021-03-09
Q4 2020 37.1M Nov 16, 2020 10-Q 2020-11-16
Q2 2020 37.1M Jul 29, 2020 10-Q 2020-08-14
Q1 2020 37.1M May 7, 2020 10-Q 2020-05-07
Q4 2018 15.6M Dec 31, 2018 20-F/A 2019-04-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.